0088B |
Acetonitrile Exposure Profile, Blood |
0148B |
Acrylonitrile Exposure Profile, Blood |
0995U |
Carbon Disulfide Exposure (TTCA), Urine |
2029U |
Ethylbenzene Exposure Biouptake, Urine |
2416U |
Aromatic Solvents Metabolites Panel, Urine |
2760ME |
Methadone and Metabolite (Qualitative), Meconium |
4213U |
Styrene Exposure Profile, Urine |
4778U |
Vinyl Chloride Metabolite, Urine |
8670ME |
Opiates - Total (Conjugated/Unconjugated) (Qualitative), Meconium |
8894OF |
Methadone and Metabolite (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |